We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Threatens Company With Seizure Over cGMP, Other Violations
FDA Threatens Company With Seizure Over cGMP, Other Violations
July 10, 2006
The FDA has issued a warning letter to Neil Laboratories, threatening the company with seizure of its products if it does not correct cGMP deviations and other violations.